Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership1,498 shares
Latest Disclosed Value $ 19,204
IFP Advisors, Inc reports 88.90% increase in ownership of NTLA / Intellia Therapeutics, Inc.

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 1,498 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $19,204 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 793 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 88.90% during the quarter. The current value of the position is $22,096 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F INTELLIA THERAPEUTICS cs 45826J105 1,498 705 88.90 19 171.43 0.0004
2026-02-06 2025-12-31 13F INTELLIA THERAPEUTICS cs 45826J105 793 -3 -0.38 7 -46.15 0.0002
2026-02-06 2025-09-30 13F/A-1 INTELLIA THERAPEUTICS cs 45826J105 796 796 14 8.33 0.0004
2025-12-02 2025-09-30 13F INTELLIA THERAPEUTICS cs 45826J105 0 0 33 0.0009
2025-07-24 2025-06-30 13F INTELLI A THERAPEUTICS cs 45826J105 0 -202 -100.00 13 1,100.00 0.0004
2025-05-05 2025-03-31 13F INTELLIA THERAPEUTICS cs 45826J105 202 181 861.90 1 0.0000
2025-02-04 2024-12-31 13F INTELLIA THERAPEUTICS cs 45826J105 21 21 0 0.0000
2025-02-04 2024-09-30 13F INTELLIA THERAPEUTICS cs 45826J105 0 -1 -100.00 0 0.0000
2024-07-30 2024-06-30 13F INTELLIA THERAPEUTICS cs 45826J105 1 1 0 0.0000
2023-10-12 2023-09-30 13F INTELLIA THERAPEUTICS cs 45826J105 0 -35 -100.00 0 -100.00
2023-08-14 2023-06-30 13F/A-1 INTELLIA THERAPEUTICS cs 45826J105 35 35 1 0.0001
2023-08-04 2023-06-30 13F INTELLIA THERAPEUTICS cs 45826J105 35 35 1 0.0000
2023-04-18 2023-03-31 13F INTELLIA THERAPEUTICS cs 45826J105 0 -228 -100.00 0 0.0000
2023-02-07 2022-12-31 13F INTELLIA THERAPEUTICS cs 45826J105 228 -50 -17.99 0 -100.00 0.0002
2022-11-08 2022-09-30 13F INTELLIA THERAPEUTICS cs 45826J105 278 0 0.00 22 0.00 0.0006
2022-09-06 2022-06-30 13F/A-1 INTELLIA THERAPEUTICS cs 45826J105 278 0 0.00 22 0.00 0.0007
2022-09-06 2022-03-31 13F/A-1 INTELLIA THERAPEUTICS cs 45826J105 278 257 1,223.81 22 633.33 0.0007
2022-08-08 2022-03-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 21 0 2 0.0000
2022-01-12 2021-12-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 21 21 3 0.0001
2021-07-13 2021-06-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 0 0 0.0000
2021-04-30 2021-03-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 0 0 0.0000
2021-01-25 2020-12-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 0 0 0.0000
2020-10-29 2020-09-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 0 0 0.0000
2020-08-05 2020-06-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 0 0 0.0000
2020-05-12 2020-03-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 0 0 0.0000
2020-01-17 2019-12-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 0 -215 -100.00 0 -100.00
2019-11-07 2019-09-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 215 0 0.00 3 -25.00 0.0002
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICSINC Stock 45826J105 215 -1,000 -82.30 4 -75.00 0.0005
2019-06-03 2018-12-31 13F/A-10 INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,215 250 25.91 16 -42.86 0.0010
2019-01-23 2018-12-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,215 250 16 0.0010
2019-06-03 2018-09-30 13F/A-9 INTELLIA THERAPEUTICS INC COM Stock 45826J105 965 -915 -48.67 28 -45.10 0.0011
2018-10-25 2018-09-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 965 -915 28 0.0011
2019-06-03 2018-06-30 13F/A-8 INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,880 130 7.43 51 50.00 0.0021
2018-08-07 2018-06-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,880 215 51
2019-06-03 2018-03-31 13F/A-7 INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,750 0 0.00 34 0.00 0.0015
2018-05-09 2018-03-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,665 -85 35
2019-06-03 2017-12-31 13F/A-6 INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,750 1,460 503.45 34 385.71 0.0015
2018-01-24 2017-12-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 1,750 1,460 34
2017-10-30 2017-09-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 290 50 20.83 7 75.00 0.0003
2019-06-03 2017-06-30 13F/A-5 INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 0 0.00 4 33.33 0.0002
2017-07-31 2017-06-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 0 4
2019-06-03 2017-03-31 13F/A-4 INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 0 0.00 3 0.00 0.0001
2017-04-26 2017-03-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 0 3
2019-06-03 2016-12-31 13F/A-3 INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 0 0.00 3 -25.00 0.0001
2017-02-14 2016-12-31 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 0 3
2016-11-04 2016-09-30 13F INTELLIA THERAPEUTICS INC COM Stock 45826J105 240 240 0.00 4 33.33 0.0002
2016-08-22 2016-06-30 13F INTELLIA THERAPEUTICSINC Stock 45826J105 0 -215 -100.00 0 -100.00
2019-06-03 2016-03-31 13F/A-1 INTELLIA THERAPEUTICSINC Stock 45826J105 215 215 4 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.